Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: A word of caution

Journal of Medical Screening

Volumn 21, Issue 1, 2014, Pages 24-29

  Duffy, Stephen W ^a   Michalopoulos, Dimitrios ^a   Sebuødegård, Sofie ^b   Hofvind, Solveig ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

Breast cancer incidence; Breast cancer screening; Overdiagnosis

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER INCIDENCE; BREAST CANCER SCREENING; BREAST TUMOR; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NORWAY; OVERDIAGNOSIS; REPRODUCIBILITY; VERY ELDERLY;

BREAST CANCER INCIDENCE; BREAST CANCER SCREENING; OVERDIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DIAGNOSTIC ERRORS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NORWAY; REPRODUCIBILITY OF RESULTS;

EID: 84901376474     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141313517676     Document Type: Article

References (14)

1. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367:1998-2005.
2. Bretthauer M, Kalager M. Principles, effectiveness and caveats in screening for cancer. Br J Surg 2013;100:55-65.
3. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778-86.
4. Duffy SW, Parmar D. Overdiagnosis in cancer screening: the importance of long term observation and lead time. Breast Cancer Research 2013;15:R41.
5. Njor SH, Garne JP, Lynge E. Over-diagnosis estimate from the Independent UK Panel on Breast Cancer Screening is based on unsuitable data. J Med Screen 2013;20:104-5.
6. Duffy SW. The benefits and harms of breast cancer screening. Lancet 2013;381:802.
7. Duffy SW, Tabar L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the breast screening programme in England. J Med Screen 2010;17:25-30.
8. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.
9. Puliti D, Zappa M, Miccinesi G, Falini P, Crocetti E, Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009;45:3166-71.
10. Hellquist BN, Duffy SW, Nystrom L, Jonsson H. Overdiagnosis in the population-based service screening programme with mammography for women aged 40-49 in Sweden. J Med Screen 2012;19:14-9.
11. Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa ME, Paci E Euroscreen Working Group. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012;19(S1): 42-56.
12. Tabar L, Dean PB, Chen T, Yen A, Chiu S, Tot T, Smith RA, Duffy SW. The impact of mammography screening on the diagnosis and management of early phase breast cancer. In: Francescatti DF, Silverstein MA, eds Selected Topics in Breast Surgery. New York, NY: Springer, 2013.
13. Kalager M, Adami HO, Bretthauer M, Tamimi RM. Overdiagnosis of breast cancer due to mammography screening: results from the Norwegian screening programme. Ann Intern Med 2012;156:491-9.
14. Hofvind S, Sakshaug S, Ursin G, Graff-Iversen S. Breast cancer incidence trends in Norway-explained by hormone therapy or mammographic screening? Int J Cancer 2012;130:2930-8.